2015
$275M
from 11 investors over 11 rounds
Pionyr Immunotherapeutics raised $275M on June 23, 2020
Investors: Gilead Sciences
Pionyr Immunotherapeutics raised $62M on December 13, 2017
Investors: OrbiMed Advisors, Vida Ventures, LLC, Mission Bay Capital, Osage University Partners (OUP), Sofinnova Ventures, Russia technology fund and QB3
Pionyr Immunotherapeutics raised $8M on January 4, 2017
Investors: OrbiMed Advisors, Osage University Partners (OUP), Mission Bay Capital and Mission BioCapital